Peripheral cytokine release in Alzheimer patients: correlation with disease severity (Q44555812)

4 December 2017

Peripheral cytokine release in Alzheimer patients: correlation with disease severity (English)

1 reference

4 December 2017

0 references

1

1 reference

4 December 2017

Maria Elisabetta Raggi

object named as

Maria Elisabetta Raggi

4

0 references

author name string

Gloria Galimberti

2

1 reference

4 December 2017

Carla Canevari

3

1 reference

4 December 2017

Valeria Isella

5

1 reference

4 December 2017

Maurizio Facheris

6

1 reference

4 December 2017

Ildebrando Appollonio

7

1 reference

4 December 2017

Carlo Ferrarese

8

1 reference

4 December 2017

1 November 2003

1 reference

4 December 2017

Neurobiology of Aging

1 reference

4 December 2017

24

1 reference

4 December 2017

7

1 reference

4 December 2017

909-914

1 reference

Inflammation and Alzheimer's disease

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Hospitalization and Alzheimer's disease: results from a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

In-vivo measurement of activated microglia in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Inflammatory markers in Alzheimer's disease and multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

Neuroendocrine regulation of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900010-1

7 January 2021

10.1016/S0197-4580(03)00010-1

Identifiers

DOI

1 reference

4 December 2017

1 reference